DR REDDYS LABORATORIES
Back to Balance Sheet
|
DR REDDYS LABORATORIES Last 5 Year Total Liabilities History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Total Liabilities | ₹55,904 Cr | ₹47,594 Cr | ₹37,806 Cr | ₹31,580 Cr | ₹28,470 Cr |
What is the latest Total Liabilities ratio of DR REDDYS LABORATORIES ?
| Year | Total Liabilities |
|---|---|
| Mar2026 | ₹55,904 Cr |
| Mar2025 | ₹47,594 Cr |
| Mar2024 | ₹37,806 Cr |
| Mar2023 | ₹31,580 Cr |
| Mar2022 | ₹28,470 Cr |
How is Total Liabilities of DR REDDYS LABORATORIES Trending?
| Years | Total Liabilities | % Change | |
|---|---|---|---|
| Mar2026 | ₹55,904 Cr | 17.46 | |
| Mar2025 | ₹47,594 Cr | 25.89 | |
| Mar2024 | ₹37,806 Cr | 19.72 | |
| Mar2023 | ₹31,580 Cr | 10.92 | |
| Mar2022 | ₹28,470 Cr | - | |
Compare Total Liabilities of peers of DR REDDYS LABORATORIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| DR REDDYS LABORATORIES | ₹99,028.8 Cr | 0.4% | 4.5% | -4.4% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹456,114.0 Cr | NA | -3.9% | 17.3% | Stock Analytics | |
| DIVIS LABORATORIES | ₹239,321.0 Cr | 5% | 21.5% | 44.5% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹185,924.0 Cr | -2.1% | -0.2% | 34.3% | Stock Analytics | |
| CIPLA | ₹113,778.0 Cr | -2% | -2.5% | -8.1% | Stock Analytics | |
| MANKIND PHARMA | ₹98,829.9 Cr | 0.3% | -8.6% | -5.5% | Stock Analytics | |
DR REDDYS LABORATORIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| DR REDDYS LABORATORIES | 0.4% |
4.5% |
-4.4% |
| SENSEX | 0.7% |
0.8% |
-5.1% |
You may also like the below Video Courses